Lalama, C. M., Jennings, C., Johnson, V. A., Coombs, R. W., McKinnon, J. E., Bremer, J. W., . . . Ribaudo, H. J. (2015). Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity. J Clin Microbiol.
Styl ChicagoLalama, Christina M., et al. "Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies Per Milliliter Despite Improved Assay Sensitivity." J Clin Microbiol 2015.
Citace podle MLALalama, Christina M., et al. "Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies Per Milliliter Despite Improved Assay Sensitivity." J Clin Microbiol 2015.